NCT02188654View on ClinicalTrials.gov

Metformin in Psoriatic Arthritis

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

April 30, 2014

Conditions
Psoriatic Arthritis
Interventions
DRUG

Metformin

500mg/day retarded formulation of metformin

DRUG

Placebo

500 mg/day of placebo tablets

Trial Locations (1)

00203

University of Alexandria, Alexandria

All Listed Sponsors
lead

University of Alexandria

OTHER

NCT02188654 - Metformin in Psoriatic Arthritis | Biotech Hunter | Biotech Hunter